Nothing Special   »   [go: up one dir, main page]

Nistala et al., 2011 - Google Patents

Th17 cells that undergo plasticity to a Th1 phenotype in human autoimmune arthritis can be detected by the expression of CD161 within the inflamed joint

Nistala et al., 2011

View PDF
Document ID
5157986164200641305
Author
Nistala K
Adams S
Cambrook H
Ursu S
Olivito B
de Jager W
Evans J
Cimaz R
Bajaj-Elliott M
Wedderburn L
et al.
Publication year
Publication venue
Clinical and Experimental Rheumatology

External Links

Snippet

OBJECTIVES: To identify genes with disease-specific expression patterns of patients diagnosed with jSpA and healthy controls using microarray-based methods. METHODOLOGY: Peripheral blood samples of 6 HLA-B27/B7, double positive “patients …
Continue reading at air.unimi.it (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/564Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders

Similar Documents

Publication Publication Date Title
US20160159918A1 (en) Methods for diagnosing and treating immune disease
JP2018506528A (en) Therapeutic targets and biomarkers in IBD
US20140037618A1 (en) Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
Khan et al. Ankylosing Spondylitis—Axial Spondyloarthritis
Nistala et al. Th17 cells that undergo plasticity to a Th1 phenotype in human autoimmune arthritis can be detected by the expression of CD161 within the inflamed joint
Dimitrios The profile of Enthesitis-Related Arthritis (ERA)–a subtype of Juvenile Idiopathic Arthritis (JIA) in Northern Greece: a retrospective cohort study
Alexeeva et al. Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study
de la Fuente-Munoz et al. Case Report: Novel STIM1 gain-of-function mutation in a patient with TAM/STRMK and immunological involvement
Vitale et al. Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
Artsymovych et al. EARLY REGISTRATION OF MYOCARDIAL DISORDERS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS USING THE 4TH GENERATION ELECTROCARDIOGRAPHY
Pinkas-Kramarski et al. Studying the Immunomodulatory Effects of Small Molecule Ras-Inhibitors in Animal Models of Rheumatoid Arthritis
Oshlianska et al. THE MAIN CHALLENGES IN THE TRANSITION OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS TO ADULT SERVICE IN UKRAINE
Gamble JSLE and the NLRP3 inflammasome–a novel therapeutic target
Oshlianska et al. THE RATIO OF SOME CYTOKINES LIKE A MARKER OPTIONS AND COURSE OF JUVENILE ARTHRITIS
Oshlianska et al. THE USE OF OFF-LABEL BIOLOGICS IN CHILDREN WITH SYSTEMIC CONNECTIVE TISSUE DISEASES
ULAŞ GÜNCAN et al. Patient Compliance and Safety of Intravenous Biological Drug Treatments in Hospital During the COVID-19 Pandemic.
Lee Paediatric Inflammatory Bowel Disease: Epidemiology and Immunopathogenesis
Tüfekçi et al. Rheumatology Congress: part 2
Villanueva Martin Deciphering the genetic basis of systemic sclerosis
De Nardo et al. Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis
Capria et al. An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients
Capria et al. Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis
Bechman The'oRAcle'Study: Identifying Predictors of Adverse Outcomes in Rheumatoid Arthritis
Conway Giant cell arteritis: diagnostic tools, treatment targets, and pathogenic pathways
McAllister et al. GENETICS AND GENOMICS OF CHRONIC INFLAMMATORY DISORDERS, II: RHEUMATOID ARTHRITIS AND RELATED ARTHROPATHIES